Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 26 | 2026 | 335 | 6.210 |
Why?
|
| Infant, Premature | 13 | 2026 | 823 | 2.850 |
Why?
|
| Infant, Newborn | 55 | 2026 | 8382 | 2.110 |
Why?
|
| Infant, Premature, Diseases | 7 | 2024 | 236 | 2.100 |
Why?
|
| Hypoxia-Ischemia, Brain | 10 | 2025 | 84 | 1.800 |
Why?
|
| Infant, Extremely Premature | 8 | 2024 | 107 | 1.560 |
Why?
|
| Noise | 2 | 2023 | 19 | 1.470 |
Why?
|
| Erythropoietin | 6 | 2022 | 105 | 1.310 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2021 | 175 | 1.220 |
Why?
|
| Gestational Age | 13 | 2024 | 1206 | 1.170 |
Why?
|
| Bronchopulmonary Dysplasia | 5 | 2026 | 211 | 1.140 |
Why?
|
| Child Development | 3 | 2023 | 265 | 1.040 |
Why?
|
| Lung Diseases | 2 | 2022 | 392 | 0.990 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 330 | 0.970 |
Why?
|
| Heart Arrest | 2 | 2021 | 359 | 0.950 |
Why?
|
| Hypothermia, Induced | 6 | 2024 | 154 | 0.950 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2025 | 475 | 0.940 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 14 | 0.910 |
Why?
|
| Hypoglycemia | 3 | 2021 | 176 | 0.820 |
Why?
|
| Infant | 26 | 2025 | 12803 | 0.810 |
Why?
|
| Anticonvulsants | 2 | 2024 | 375 | 0.760 |
Why?
|
| Brain Diseases | 1 | 2025 | 280 | 0.740 |
Why?
|
| Tocolytic Agents | 1 | 2022 | 12 | 0.740 |
Why?
|
| Needs Assessment | 1 | 2023 | 170 | 0.740 |
Why?
|
| Phenobarbital | 1 | 2021 | 30 | 0.720 |
Why?
|
| Parents | 4 | 2021 | 1073 | 0.690 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 196 | 0.670 |
Why?
|
| Visitors to Patients | 1 | 2020 | 9 | 0.670 |
Why?
|
| Incubators, Infant | 1 | 2020 | 4 | 0.670 |
Why?
|
| Papaver | 1 | 2020 | 4 | 0.670 |
Why?
|
| Hospital Administration | 1 | 2020 | 22 | 0.670 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 19 | 0.650 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.640 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 53 | 0.630 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 58 | 0.620 |
Why?
|
| Neuroprotection | 1 | 2019 | 28 | 0.620 |
Why?
|
| Infection Control | 1 | 2020 | 155 | 0.610 |
Why?
|
| Humans | 57 | 2026 | 126153 | 0.600 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 41 | 0.590 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 357 | 0.580 |
Why?
|
| Hypernatremia | 1 | 2019 | 32 | 0.580 |
Why?
|
| Epoprostenol | 1 | 2018 | 42 | 0.570 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 247 | 0.570 |
Why?
|
| Hyponatremia | 1 | 2019 | 71 | 0.560 |
Why?
|
| Infant, Low Birth Weight | 4 | 2025 | 166 | 0.550 |
Why?
|
| Sodium | 1 | 2019 | 273 | 0.550 |
Why?
|
| United States | 13 | 2025 | 11191 | 0.540 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 151 | 0.540 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 84 | 0.530 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 190 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.520 |
Why?
|
| Retrospective Studies | 15 | 2025 | 16831 | 0.490 |
Why?
|
| Nitric Oxide | 2 | 2018 | 462 | 0.480 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 623 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.460 |
Why?
|
| Resuscitation | 1 | 2017 | 269 | 0.450 |
Why?
|
| Pregnancy | 12 | 2025 | 7397 | 0.450 |
Why?
|
| Mass Screening | 1 | 2020 | 802 | 0.440 |
Why?
|
| Female | 32 | 2026 | 68045 | 0.430 |
Why?
|
| Hemorrhage | 1 | 2018 | 468 | 0.430 |
Why?
|
| Pandemics | 1 | 2020 | 1125 | 0.390 |
Why?
|
| Hypothermia | 2 | 2023 | 60 | 0.390 |
Why?
|
| Electroencephalography | 4 | 2025 | 845 | 0.390 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3658 | 0.380 |
Why?
|
| Milk, Human | 3 | 2021 | 308 | 0.380 |
Why?
|
| Typhoid Fever | 1 | 2011 | 18 | 0.360 |
Why?
|
| Salmonella typhi | 1 | 2011 | 21 | 0.360 |
Why?
|
| Retinopathy of Prematurity | 2 | 2024 | 63 | 0.350 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3895 | 0.340 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 146 | 0.330 |
Why?
|
| Male | 24 | 2026 | 62235 | 0.320 |
Why?
|
| Prevalence | 4 | 2025 | 2572 | 0.310 |
Why?
|
| Texas | 3 | 2025 | 3536 | 0.300 |
Why?
|
| Dietary Supplements | 4 | 2024 | 437 | 0.280 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 523 | 0.270 |
Why?
|
| Premature Birth | 2 | 2022 | 415 | 0.250 |
Why?
|
| Patient Selection | 2 | 2021 | 698 | 0.240 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 80 | 0.240 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2026 | 59 | 0.230 |
Why?
|
| Syphilis, Congenital | 1 | 2025 | 32 | 0.230 |
Why?
|
| Decision Making | 2 | 2021 | 665 | 0.220 |
Why?
|
| Seizures | 3 | 2024 | 853 | 0.210 |
Why?
|
| Incubators | 1 | 2023 | 2 | 0.210 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 70 | 0.200 |
Why?
|
| Sound | 1 | 2023 | 22 | 0.200 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 89 | 0.200 |
Why?
|
| Birth Weight | 3 | 2022 | 343 | 0.200 |
Why?
|
| Weight Gain | 2 | 2023 | 376 | 0.200 |
Why?
|
| Vitamin D | 1 | 2024 | 174 | 0.190 |
Why?
|
| Oximetry | 1 | 2024 | 174 | 0.190 |
Why?
|
| Neonatology | 1 | 2023 | 56 | 0.190 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 38 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2025 | 4894 | 0.190 |
Why?
|
| Palivizumab | 1 | 2022 | 46 | 0.190 |
Why?
|
| Tocolysis | 1 | 2022 | 4 | 0.190 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 109 | 0.180 |
Why?
|
| Mothers | 1 | 2025 | 363 | 0.180 |
Why?
|
| Status Epilepticus | 1 | 2023 | 151 | 0.180 |
Why?
|
| Administration, Intravenous | 2 | 2022 | 165 | 0.180 |
Why?
|
| Magnesium Sulfate | 1 | 2022 | 51 | 0.180 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2022 | 79 | 0.180 |
Why?
|
| Phenytoin | 1 | 2021 | 57 | 0.180 |
Why?
|
| Refusal to Participate | 1 | 2021 | 3 | 0.170 |
Why?
|
| Breast Feeding | 2 | 2021 | 227 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 155 | 0.170 |
Why?
|
| Parental Consent | 1 | 2021 | 22 | 0.170 |
Why?
|
| Patients' Rooms | 1 | 2020 | 8 | 0.170 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 12 | 0.170 |
Why?
|
| Placenta Diseases | 1 | 2021 | 64 | 0.170 |
Why?
|
| Probiotics | 1 | 2023 | 222 | 0.170 |
Why?
|
| Equipment Safety | 1 | 2020 | 37 | 0.170 |
Why?
|
| Tea | 1 | 2020 | 18 | 0.170 |
Why?
|
| Infant Health | 1 | 2020 | 16 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 545 | 0.170 |
Why?
|
| Policy Making | 1 | 2020 | 59 | 0.160 |
Why?
|
| Codeine | 1 | 2020 | 21 | 0.160 |
Why?
|
| Organizational Policy | 1 | 2020 | 49 | 0.160 |
Why?
|
| Registries | 2 | 2025 | 1478 | 0.160 |
Why?
|
| Echoencephalography | 1 | 2020 | 26 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 75 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2025 | 546 | 0.160 |
Why?
|
| Cholestasis | 1 | 2022 | 164 | 0.160 |
Why?
|
| Seeds | 1 | 2020 | 41 | 0.160 |
Why?
|
| Child, Preschool | 7 | 2025 | 14375 | 0.160 |
Why?
|
| Drug Evaluation | 1 | 2019 | 102 | 0.160 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2019 | 2 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 142 | 0.150 |
Why?
|
| Rhombencephalon | 2 | 2009 | 57 | 0.150 |
Why?
|
| Manikins | 1 | 2020 | 138 | 0.150 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 23 | 0.150 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 45 | 0.150 |
Why?
|
| Eye Diseases | 1 | 2019 | 80 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 166 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 285 | 0.140 |
Why?
|
| Food, Fortified | 1 | 2018 | 62 | 0.140 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 88 | 0.140 |
Why?
|
| Eating | 1 | 2020 | 359 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 184 | 0.140 |
Why?
|
| Pulmonary Surfactants | 1 | 2018 | 45 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 284 | 0.140 |
Why?
|
| Phospholipids | 1 | 2018 | 100 | 0.130 |
Why?
|
| Double-Blind Method | 4 | 2022 | 1596 | 0.130 |
Why?
|
| Hospitals | 1 | 2020 | 411 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2020 | 352 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2022 | 777 | 0.130 |
Why?
|
| Infant Mortality | 1 | 2018 | 177 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 692 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 279 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 422 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1107 | 0.120 |
Why?
|
| Biological Products | 1 | 2018 | 137 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 601 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 332 | 0.120 |
Why?
|
| Informed Consent | 1 | 2018 | 336 | 0.120 |
Why?
|
| Child | 4 | 2024 | 25112 | 0.110 |
Why?
|
| Liver | 1 | 2002 | 1767 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1571 | 0.110 |
Why?
|
| Glucose | 1 | 2019 | 845 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 530 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1739 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1086 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1171 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1294 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 746 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 1811 | 0.100 |
Why?
|
| Epilepsy | 1 | 2021 | 846 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 709 | 0.100 |
Why?
|
| Biomarkers | 2 | 2020 | 3150 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3306 | 0.090 |
Why?
|
| Adult | 4 | 2025 | 30315 | 0.090 |
Why?
|
| Pakistan | 1 | 2011 | 91 | 0.090 |
Why?
|
| Proprioception | 1 | 2009 | 17 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12393 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 44 | 0.080 |
Why?
|
| Arousal | 1 | 2009 | 77 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1840 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2927 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 79 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6030 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2008 | 190 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1408 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2008 | 244 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 138 | 0.070 |
Why?
|
| Risk Factors | 3 | 2022 | 10376 | 0.070 |
Why?
|
| Neonatal Nursing | 1 | 2026 | 6 | 0.060 |
Why?
|
| Brain | 3 | 2024 | 3029 | 0.060 |
Why?
|
| Asphyxia Neonatorum | 1 | 2025 | 15 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 1180 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 6178 | 0.060 |
Why?
|
| Penicillins | 1 | 2025 | 155 | 0.060 |
Why?
|
| Mother-Child Relations | 1 | 2025 | 76 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 677 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2024 | 279 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 225 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2009 | 3719 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 1923 | 0.050 |
Why?
|
| Asphyxia | 1 | 2022 | 12 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 21 | 0.050 |
Why?
|
| Hepcidins | 1 | 2002 | 27 | 0.050 |
Why?
|
| Olive Oil | 1 | 2022 | 24 | 0.050 |
Why?
|
| Indomethacin | 1 | 2022 | 81 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 88 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2022 | 71 | 0.050 |
Why?
|
| Fish Oils | 1 | 2022 | 82 | 0.050 |
Why?
|
| Albuminuria | 1 | 2022 | 95 | 0.050 |
Why?
|
| Spleen | 1 | 2002 | 251 | 0.050 |
Why?
|
| Bilirubin | 1 | 2022 | 124 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3593 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2021 | 85 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5107 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 77 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 251 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2019 | 5 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1318 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 599 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 63 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 295 | 0.040 |
Why?
|
| Pacifiers | 1 | 2019 | 4 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2019 | 75 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 70 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 156 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2009 | 200 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1040 | 0.040 |
Why?
|
| Vomiting | 1 | 2018 | 99 | 0.030 |
Why?
|
| Incidence | 1 | 2025 | 3193 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 422 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 461 | 0.030 |
Why?
|
| Acidosis | 1 | 2018 | 100 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 224 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 736 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 17626 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2019 | 240 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 541 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1598 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2021 | 1180 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2554 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 365 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 357 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4697 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 486 | 0.030 |
Why?
|
| Cell Movement | 2 | 2009 | 846 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 950 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2319 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2509 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 33235 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Auditory Pathways | 1 | 2009 | 19 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 21 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 60 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 52 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2009 | 41 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 82 | 0.020 |
Why?
|
| Levodopa | 1 | 2009 | 94 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 31 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 376 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 821 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 260 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 455 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 206 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 245 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 540 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 973 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2358 | 0.010 |
Why?
|